SCHEMBL19011036

SCHEMBL19011036

Cc1ccccc1-c1ccc(-c2ccccc2)c2oc3ccccc3c12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDC14B O60729 2/20 0.49
▸ CDC14A Q9UNH5 2/20 0.49
▸ NPC1 O15118 2/20 0.41
▸ RAB9A P51151 2/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ CSF1R P07333 1/20 0.41
▸ PDGFRB P09619 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ KIT P10721 1/20 0.41
▸ FLT3 P36888 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ HDAC6 Q9UBN7 1/20 0.41
▸ CYP17A1 P05093 1/20 0.39
▸ CYP19A1 P11511 1/20 0.39
▸ CYP11B1 P15538 1/20 0.39
▸ CYP11B2 P19099 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19011040 0.94 CDC14B (0.46) CDC14BCDC14ANPC1RAB9ASMN1; SMN2
SCHEMBL19011017 0.85 CDC14B (0.52) CDC14BCDC14ANPC1RAB9ASMN1; SMN2
SCHEMBL26750813 0.85 CDC14B (0.55) CDC14BCDC14ANPC1RAB9ASMN1; SMN2
SCHEMBL12203192 0.85 CDC14B (0.57) CDC14BCDC14ANPC1RAB9ASMN1; SMN2
SCHEMBL16283902 0.84 CDC14B (0.48) CDC14BCDC14ANPC1RAB9ASMN1; SMN2
SCHEMBL19011041 0.83 CDC14B (0.50) CDC14BCDC14ANPC1RAB9ASMN1; SMN2
SCHEMBL19011039 0.83 CDC14B (0.50) CDC14BCDC14ANPC1RAB9ASMN1; SMN2
SCHEMBL20462445 0.81 CDC14B (0.49) CDC14BCDC14ANPC1RAB9ASMN1; SMN2
SCHEMBL16261659 0.81 ALOX5 (0.44) CDC14BCDC14ANPC1RAB9ASMN1; SMN2
SCHEMBL28497479 0.80 CDC14B (0.48) CDC14BCDC14ANPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11832513-B2 Materials for electronic devices MERCK PATENT GMBH (DE) 2023-11-28 — — US disclosed
US-11832513-B2 Materials for electronic devices MERCK PATENT GMBH (DE) 2023-11-28 — — US disclosed
EP-4242286-A2 MATERIALS FOR ELECTRONIC DEVICES Merck Patent GmbH (DE) 2023-09-13 — — EP disclosed
US-20200303654-A1 MATERIALS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2020-09-24 — — US disclosed
WO-2017102064-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2017-06-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11832513-B2 Materials for electronic devices PNMT, DDT, COMT CDC14B 3291/4885CDC14A 2930/4885NPC1 1893/4885
US-20200303654-A1 MATERIALS FOR ELECTRONIC DEVICES PNMT, DDT, COMT CDC14B 3291/4885CDC14A 2930/4885NPC1 1893/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback